David Lewis
Stock Analyst at Morgan Stanley
(1.68)
# 2,082
Out of 4,433 analysts
139
Total ratings
64.96%
Success rate
8.47%
Average return
Main Sectors:
28 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Maintains: Equal-Weight | $112 → $107 | $104.09 | +2.80% | 10 | Oct 19, 2023 | |
| NTLA Intellia Therapeutics | Maintains: Neutral | $44 → $40 | $26.22 | +52.56% | 2 | Aug 4, 2023 | |
| PODD Insulet | Maintains: Equal-Weight | $273 → $300 | $187.27 | +60.20% | 7 | Nov 4, 2022 | |
| BDX Becton, Dickinson and Company | Maintains: Overweight | $272 → $275 | $236.30 | +16.38% | 9 | Oct 11, 2022 | |
| NVRO Nevro | Maintains: Equal-Weight | $55 → $54 | $11.40 | +373.68% | 7 | Aug 4, 2022 | |
| DXCM DexCom | Maintains: Equal-Weight | $91 → $91 | $131.36 | -30.72% | 13 | Jun 15, 2022 | |
| OM Outset Medical | Maintains: Overweight | $50 → $48 | $3.61 | +1,229.64% | 2 | May 5, 2022 | |
| BAX Baxter International | Maintains: Overweight | $105 → $100 | $35.25 | +183.69% | 10 | Apr 29, 2022 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $22 → $15 | $137.98 | -89.13% | 3 | Feb 25, 2022 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $37 → $30 | $9.00 | +233.33% | 3 | Feb 25, 2022 | |
| AXNX Axonics | Maintains: Overweight | $73 → $69 | $67.55 | +2.15% | 3 | Feb 25, 2022 | |
| SWAV ShockWave Medical | Maintains: Equal-Weight | $210 → $199 | $330.13 | -39.72% | 5 | Feb 18, 2022 | |
| HOLX Hologic | Maintains: Equal-Weight | $76 → $75 | $75.02 | -0.03% | 3 | Feb 3, 2022 | |
| NVST Envista Holdings | Maintains: Equal-Weight | $42 → $45 | $18.53 | +142.85% | 2 | Jan 7, 2022 | |
| HAE Haemonetics | Maintains: Equal-Weight | $68 → $60 | $95.73 | -37.32% | 9 | Jan 7, 2022 | |
| GMED Globus Medical | Maintains: Equal-Weight | $80 → $82 | $64.40 | +27.33% | 3 | Jan 7, 2022 | |
| MDT Medtronic | Maintains: Overweight | n/a | $85.92 | - | 10 | Aug 25, 2021 | |
| IRTC iRhythm Technologies | Downgrades: Equal-Weight | n/a | $94.83 | - | 2 | Apr 14, 2021 | |
| SIBN SI-BONE | Maintains: Overweight | n/a | $14.92 | - | 2 | Mar 9, 2021 | |
| BVS Bioventus | Initiates: Overweight | n/a | $6.38 | - | 1 | Mar 8, 2021 | |
| ALC Alcon | Maintains: Overweight | n/a | $88.83 | - | 3 | Feb 25, 2021 | |
| ZBH Zimmer Biomet Holdings | Maintains: Overweight | n/a | $120.18 | - | 9 | Feb 8, 2021 | |
| SYK Stryker | Maintains: Overweight | n/a | $334.68 | - | 2 | Jan 28, 2021 | |
| ISRG Intuitive Surgical | Downgrades: Equal-Weight | n/a | $398.82 | - | 8 | Dec 15, 2020 | |
| EW Edwards Lifesciences | Maintains: Overweight | n/a | $89.14 | - | 2 | Apr 24, 2020 | |
| TFX Teleflex | Maintains: Overweight | n/a | $217.64 | - | 1 | Mar 27, 2020 | |
| JNJ Johnson & Johnson | Maintains: Overweight | n/a | $154.64 | - | 7 | Mar 27, 2020 | |
| AVNS Avanos Medical | Maintains: Underweight | n/a | $20.39 | - | 1 | Mar 27, 2020 |
Abbott Laboratories
Oct 19, 2023
Maintains: Equal-Weight
Price Target: $112 → $107
Current: $104.09
Upside: +2.80%
Intellia Therapeutics
Aug 4, 2023
Maintains: Neutral
Price Target: $44 → $40
Current: $26.22
Upside: +52.56%
Insulet
Nov 4, 2022
Maintains: Equal-Weight
Price Target: $273 → $300
Current: $187.27
Upside: +60.20%
Becton, Dickinson and Company
Oct 11, 2022
Maintains: Overweight
Price Target: $272 → $275
Current: $236.30
Upside: +16.38%
Nevro
Aug 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $54
Current: $11.40
Upside: +373.68%
DexCom
Jun 15, 2022
Maintains: Equal-Weight
Price Target: $91 → $91
Current: $131.36
Upside: -30.72%
Outset Medical
May 5, 2022
Maintains: Overweight
Price Target: $50 → $48
Current: $3.61
Upside: +1,229.64%
Baxter International
Apr 29, 2022
Maintains: Overweight
Price Target: $105 → $100
Current: $35.25
Upside: +183.69%
TransMedics Group
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $22 → $15
Current: $137.98
Upside: -89.13%
Pulmonx
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $37 → $30
Current: $9.00
Upside: +233.33%
Axonics
Feb 25, 2022
Maintains: Overweight
Price Target: $73 → $69
Current: $67.55
Upside: +2.15%
ShockWave Medical
Feb 18, 2022
Maintains: Equal-Weight
Price Target: $210 → $199
Current: $330.13
Upside: -39.72%
Hologic
Feb 3, 2022
Maintains: Equal-Weight
Price Target: $76 → $75
Current: $75.02
Upside: -0.03%
Envista Holdings
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $42 → $45
Current: $18.53
Upside: +142.85%
Haemonetics
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $68 → $60
Current: $95.73
Upside: -37.32%
Globus Medical
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $80 → $82
Current: $64.40
Upside: +27.33%
Medtronic
Aug 25, 2021
Maintains: Overweight
Price Target: n/a
Current: $85.92
Upside: -
iRhythm Technologies
Apr 14, 2021
Downgrades: Equal-Weight
Price Target: n/a
Current: $94.83
Upside: -
SI-BONE
Mar 9, 2021
Maintains: Overweight
Price Target: n/a
Current: $14.92
Upside: -
Bioventus
Mar 8, 2021
Initiates: Overweight
Price Target: n/a
Current: $6.38
Upside: -
Alcon
Feb 25, 2021
Maintains: Overweight
Price Target: n/a
Current: $88.83
Upside: -
Zimmer Biomet Holdings
Feb 8, 2021
Maintains: Overweight
Price Target: n/a
Current: $120.18
Upside: -
Stryker
Jan 28, 2021
Maintains: Overweight
Price Target: n/a
Current: $334.68
Upside: -
Intuitive Surgical
Dec 15, 2020
Downgrades: Equal-Weight
Price Target: n/a
Current: $398.82
Upside: -
Edwards Lifesciences
Apr 24, 2020
Maintains: Overweight
Price Target: n/a
Current: $89.14
Upside: -
Teleflex
Mar 27, 2020
Maintains: Overweight
Price Target: n/a
Current: $217.64
Upside: -
Johnson & Johnson
Mar 27, 2020
Maintains: Overweight
Price Target: n/a
Current: $154.64
Upside: -
Avanos Medical
Mar 27, 2020
Maintains: Underweight
Price Target: n/a
Current: $20.39
Upside: -